We are live on ! Find out more
ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
Reduced
Closed
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
MA
126
MUFG Americas
New York
$208K +$218K +53 New
HSBC Holdings
127
HSBC Holdings
United Kingdom
$203K +$210K +51 New
MSA
128
Mason Street Advisors
Wisconsin
$185K +$194K +47 New
STC
129
SEI Trust Company
Pennsylvania
$181K +$189K +46 New
PI
130
PineBridge Investments
New York
$151K +$156K +38 New
MCM
131
Matarin Capital Management
New York
$145K +$152K +37 New
CBOA
132
Commonwealth Bank of Australia
Australia
$112K +$115K +28 New
Teacher Retirement System of Texas
133
Teacher Retirement System of Texas
Texas
$86K +$90.6K +22 New
OA
134
OFI Advisors
Pennsylvania
$85K +$86.5K +21 New
Citigroup
135
Citigroup
New York
$71K +$74.1K +18 New
Fuller & Thaler Asset Management
136
Fuller & Thaler Asset Management
California
$69K +$74.1K +18 New
ILIM
137
Irish Life Investment Managers
Ireland
$57.5K +$61.8K +15 New
Group One Trading
138
Group One Trading
Illinois
$26K +$28.8K +7 New
TRCT
139
Tower Research Capital (TRC)
New York
$26K +$28.8K +7 New
PNC Financial Services Group
140
PNC Financial Services Group
Pennsylvania
$23K +$24.7K +6 New
WTC
141
WhitTier Trust Company
Nevada
$22K +$20.6K +5 New
OMCS
142
Old Mutual Customised Solutions
South Africa
$16K +$16.5K +4 New
EWM
143
Evercore Wealth Management
New York
$13K +$12.4K +3 New
Royal Bank of Canada
144
Royal Bank of Canada
Ontario, Canada
$13K +$12.4K +3 New
Jones Financial Companies
145
Jones Financial Companies
Missouri
$10K +$12.4K +3 New
LTFS
146
Ladenburg Thalmann Financial Services
Florida
$3K +$4.12K +1 New
PTC
147
Private Trust Company
Ohio
$2K +$4.12K +1 New
Envestnet Asset Management
148
Envestnet Asset Management
Illinois
$1K
Thrivent Financial for Lutherans
149
Thrivent Financial for Lutherans
Minnesota
$488 +$506K +123 New

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.